Sartorius Stedim Biotech SA
PAR:DIM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Hormel Foods Corp
NYSE:HRL
|
Food Products
|
| US |
|
Philip Morris International Inc
NYSE:PM
|
Tobacco
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
Procter & Gamble Co
NYSE:PG
|
Consumer products
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Booking Holdings Inc
NASDAQ:BKNG
|
Hotels, Restaurants & Leisure
|
| US |
|
Intel Corp
NASDAQ:INTC
|
Semiconductors
|
| US |
|
Match Group Inc
NASDAQ:MTCH
|
Media
|
| US |
|
Apple Inc
NASDAQ:AAPL
|
Technology
|
| US |
|
NVIDIA Corp
NASDAQ:NVDA
|
Semiconductors
|
| US |
|
Alphabet Inc
NASDAQ:GOOGL
|
Media
|
| US |
|
Meta Platforms Inc
NASDAQ:META
|
Media
|
| US |
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
145.35
280
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Hormel Foods Corp
NYSE:HRL
|
US |
|
|
Philip Morris International Inc
NYSE:PM
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
Procter & Gamble Co
NYSE:PG
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Booking Holdings Inc
NASDAQ:BKNG
|
US |
|
|
Intel Corp
NASDAQ:INTC
|
US |
|
|
Match Group Inc
NASDAQ:MTCH
|
US |
|
|
Apple Inc
NASDAQ:AAPL
|
US |
|
|
NVIDIA Corp
NASDAQ:NVDA
|
US |
|
|
Alphabet Inc
NASDAQ:GOOGL
|
US |
|
|
Meta Platforms Inc
NASDAQ:META
|
US |
|
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
US |
This alert will be permanently deleted.
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA
Effect of Foreign Exchange Rates
Sartorius Stedim Biotech SA
Effect of Foreign Exchange Rates Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Effect of Foreign Exchange Rates | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sartorius Stedim Biotech SA
PAR:DIM
|
Effect of Foreign Exchange Rates
-€1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
|
Pcas SA
PAR:PCA
|
Effect of Foreign Exchange Rates
€501k
|
CAGR 3-Years
694%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eurofins-Cerep SA
PAR:ALECR
|
Effect of Foreign Exchange Rates
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sartorius Stedim Biotech SA
Glance View
Sartorius Stedim Biotech SA, a key player in the biopharmaceutical industry, has positioned itself at the forefront of innovation in bioprocessing and laboratory solutions. Established in the early 2000s through the merger of Sartorius AG's biotech division and Stedim S.A., the company’s mission centers on enabling the development and production of life-saving biologics. With a comprehensive portfolio that includes bioprocessing equipment, research services, and laboratory instruments, Sartorius caters to a vast array of customers, from small biotech firms to large pharmaceuticals, ensuring seamless workflows in drug development and manufacturing. By leveraging cutting-edge technologies and maintaining a commitment to sustainability, Sartorius has built a reputation as a trusted partner in the industry, addressing the growing demand for effective therapies amidst an ever-evolving healthcare landscape. As the global biopharmaceutical market expands, driven by advancements in personalized medicine and precision therapies, Sartorius is well-positioned to capitalize on these trends. The company’s recent strategic acquisitions and investments in digitalization and automation enhance its product offerings, allowing clients to improve efficiencies and reduce time-to-market for essential therapeutics. Boasting a strong financial track record and a commitment to research and development, Sartorius Stedim Biotech SA not only ensures consistent growth but also aligns with long-term health sector trends. For investors, this combination of strategic vision, robust market position, and innovative capabilities makes Sartorius an attractive investment opportunity in the booming biotechnology sector.
See Also
What is Sartorius Stedim Biotech SA's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-1.2m
EUR
Based on the financial report for Jun 30, 2024, Sartorius Stedim Biotech SA's Effect of Foreign Exchange Rates amounts to -1.2m EUR.
What is Sartorius Stedim Biotech SA's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 10Y
3%
You don't have any saved screeners yet
